[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Flu Vaccine-Global Market Status and Trend Report 2013-2023

December 2017 | 155 pages | ID: F1AA4660219EN
MIReports Co., Limited

US$ 2,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Flu Vaccine-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Flu Vaccine industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of Flu Vaccine 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Flu Vaccine worldwide, with company and product introduction, position in the Flu Vaccine market
Market status and development trend of Flu Vaccine by types and applications
Cost and profit status of Flu Vaccine, and marketing status
Market growth drivers and challenges

The report segments the global Flu Vaccine market as:

Global Flu Vaccine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North America
Europe
China
Japan
Rest APAC
Latin America

Global Flu Vaccine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Whole Virus Vaccines
Split Virus Vaccines
Subunit Or Surface Antigen Vaccines
Live Attenuated (Cold-Adapted) Virus Vaccines

Global Flu Vaccine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
For Children (6 months to 3 years old)
For Adult and Children over 3 years

Global Flu Vaccine Market: Manufacturers Segment Analysis (Company and Product introduction, Flu Vaccine Sales Volume, Revenue, Price and Gross Margin):

Sanofi-pasteur
Novartis
GSK
Abbott
Pfizer
CSL
Hualan Bio
Changchun Bio
Alephbio
Sinovac
CS Vaccine
Tianyuan Bio
Tiantan Bio
Siobp

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

CHAPTER 1 OVERVIEW OF FLU VACCINE

1.1 Definition of Flu Vaccine in This Report
1.2 Commercial Types of Flu Vaccine
  1.2.1 Whole Virus Vaccines
  1.2.2 Split Virus Vaccines
  1.2.3 Subunit Or Surface Antigen Vaccines
  1.2.4 Live Attenuated (Cold-Adapted) Virus Vaccines
1.3 Downstream Application of Flu Vaccine
  1.3.1 For Children (6 months to 3 years old)
  1.3.2 For Adult and Children over 3 years
1.4 Development History of Flu Vaccine
1.5 Market Status and Trend of Flu Vaccine 2013-2023
  1.5.1 Global Flu Vaccine Market Status and Trend 2013-2023
  1.5.2 Regional Flu Vaccine Market Status and Trend 2013-2023

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Flu Vaccine 2013-2017
2.2 Production Market of Flu Vaccine by Regions
  2.2.1 Production Volume of Flu Vaccine by Regions
  2.2.2 Production Value of Flu Vaccine by Regions
2.3 Demand Market of Flu Vaccine by Regions
2.4 Production and Demand Status of Flu Vaccine by Regions
  2.4.1 Production and Demand Status of Flu Vaccine by Regions 2013-2017
  2.4.2 Import and Export Status of Flu Vaccine by Regions 2013-2017

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Production Volume of Flu Vaccine by Types
3.2 Production Value of Flu Vaccine by Types
3.3 Market Forecast of Flu Vaccine by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Flu Vaccine by Downstream Industry
4.2 Market Forecast of Flu Vaccine by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF FLU VACCINE

5.1 Global Economy Situation and Trend Overview
5.2 Flu Vaccine Downstream Industry Situation and Trend Overview

CHAPTER 6 FLU VACCINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

6.1 Production Volume of Flu Vaccine by Major Manufacturers
6.2 Production Value of Flu Vaccine by Major Manufacturers
6.3 Basic Information of Flu Vaccine by Major Manufacturers
  6.3.1 Headquarters Location and Established Time of Flu Vaccine Major Manufacturer
  6.3.2 Employees and Revenue Level of Flu Vaccine Major Manufacturer
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 FLU VACCINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Sanofi-pasteur
  7.1.1 Company profile
  7.1.2 Representative Flu Vaccine Product
  7.1.3 Flu Vaccine Sales, Revenue, Price and Gross Margin of Sanofi-pasteur
7.2 Novartis
  7.2.1 Company profile
  7.2.2 Representative Flu Vaccine Product
  7.2.3 Flu Vaccine Sales, Revenue, Price and Gross Margin of Novartis
7.3 GSK
  7.3.1 Company profile
  7.3.2 Representative Flu Vaccine Product
  7.3.3 Flu Vaccine Sales, Revenue, Price and Gross Margin of GSK
7.4 Abbott
  7.4.1 Company profile
  7.4.2 Representative Flu Vaccine Product
  7.4.3 Flu Vaccine Sales, Revenue, Price and Gross Margin of Abbott
7.5 Pfizer
  7.5.1 Company profile
  7.5.2 Representative Flu Vaccine Product
  7.5.3 Flu Vaccine Sales, Revenue, Price and Gross Margin of Pfizer
7.6 CSL
  7.6.1 Company profile
  7.6.2 Representative Flu Vaccine Product
  7.6.3 Flu Vaccine Sales, Revenue, Price and Gross Margin of CSL
7.7 Hualan Bio
  7.7.1 Company profile
  7.7.2 Representative Flu Vaccine Product
  7.7.3 Flu Vaccine Sales, Revenue, Price and Gross Margin of Hualan Bio
7.8 Changchun Bio
  7.8.1 Company profile
  7.8.2 Representative Flu Vaccine Product
  7.8.3 Flu Vaccine Sales, Revenue, Price and Gross Margin of Changchun Bio
7.9 Alephbio
  7.9.1 Company profile
  7.9.2 Representative Flu Vaccine Product
  7.9.3 Flu Vaccine Sales, Revenue, Price and Gross Margin of Alephbio
7.10 Sinovac
  7.10.1 Company profile
  7.10.2 Representative Flu Vaccine Product
  7.10.3 Flu Vaccine Sales, Revenue, Price and Gross Margin of Sinovac
7.11 CS Vaccine
  7.11.1 Company profile
  7.11.2 Representative Flu Vaccine Product
  7.11.3 Flu Vaccine Sales, Revenue, Price and Gross Margin of CS Vaccine
7.12 Tianyuan Bio
  7.12.1 Company profile
  7.12.2 Representative Flu Vaccine Product
  7.12.3 Flu Vaccine Sales, Revenue, Price and Gross Margin of Tianyuan Bio
7.13 Tiantan Bio
  7.13.1 Company profile
  7.13.2 Representative Flu Vaccine Product
  7.13.3 Flu Vaccine Sales, Revenue, Price and Gross Margin of Tiantan Bio
7.14 Siobp
  7.14.1 Company profile
  7.14.2 Representative Flu Vaccine Product
  7.14.3 Flu Vaccine Sales, Revenue, Price and Gross Margin of Siobp

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF FLU VACCINE

8.1 Industry Chain of Flu Vaccine
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF FLU VACCINE

9.1 Cost Structure Analysis of Flu Vaccine
9.2 Raw Materials Cost Analysis of Flu Vaccine
9.3 Labor Cost Analysis of Flu Vaccine
9.4 Manufacturing Expenses Analysis of Flu Vaccine

CHAPTER 10 MARKETING STATUS ANALYSIS OF FLU VACCINE

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications